BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 10912944)

  • 41. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
    De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
    Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Value of interphase FISH for the diagnosis of t(11:14)(q13;q32) on skin lesions of mantle cell lymphoma.
    Dubus P; Young P; Beylot-Barry M; Belaud-Rotureau MA; Courville P; Vergier B; Parrens M; Lenormand B; Joly P; Merlio JP
    Am J Clin Pathol; 2002 Dec; 118(6):832-41. PubMed ID: 12472275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases.
    Schlette E; Fu K; Medeiros LJ
    Am J Clin Pathol; 2003 Nov; 120(5):760-6. PubMed ID: 14608904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mantle cell lymphoma presenting with unusual morphology in an adolescent female: a case report and review of the literature.
    Smock KJ; Yaish HM; Cairo MS; Lones MA; Willmore-Payne C; Perkins SL
    Pediatr Dev Pathol; 2007; 10(5):403-8. PubMed ID: 17929987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma.
    Barranco C; Mate JL; Ariza A; Baró T; Díaz E; Munné A; Serrano S
    Mod Pathol; 2003 Feb; 16(2):161-5. PubMed ID: 12591969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.
    Kimura Y; Sato K; Imamura Y; Arakawa F; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Niino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Ohshima K
    Cancer Sci; 2011 Sep; 102(9):1734-41. PubMed ID: 21609366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclin D1 and t(11;14)-positive B-cell neoplasms resembling marginal zone B-cell lymphoma: a morphological variant of mantle cell lymphoma.
    Mansoor A; Akbari M; Auer I; Lai R
    Hum Pathol; 2007 May; 38(5):797-802. PubMed ID: 17316759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
    Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK
    J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. bcl-1 translocations are frequent in the paraimmunoblastic variant of small lymphocytic lymphoma.
    Grosso LE; Kelley PD
    Mod Pathol; 1998 Jan; 11(1):6-10. PubMed ID: 9556424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Instances of mantle cell lymphoma morphologically mimicking other subtypes of B-cell lymphoid proliferation.
    Schuetz MJ; Zafar N; Vasef MA
    South Med J; 2009 Apr; 102(4):369-73. PubMed ID: 19279536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The splenic form of mantle cell lymphoma.
    Angelopoulou MK; Siakantariz MP; Vassilakopoulos TP; Kontopidou FN; Rassidakis GZ; Dimopoulou MN; Kittas C; Pangalis GA
    Eur J Haematol; 2002 Jan; 68(1):12-21. PubMed ID: 11952817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. De novo CD5+ Burkitt lymphoma/leukemia.
    Lin CW; O'Brien S; Faber J; Manshouri T; Romaguera J; Huh YO; Kantarjian H; Keating M; Albitar M
    Am J Clin Pathol; 1999 Dec; 112(6):828-35. PubMed ID: 10587706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
    Ondrejka SL; Lai R; Smith SD; Hsi ED
    Haematologica; 2011 Aug; 96(8):1121-7. PubMed ID: 21508124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
    Savilo E; Campo E; Mollejo M; Pinyol M; Piris MA; Zukerberg LR; Yang WI; Koelliker DD; Nguyen PL; Harris NL
    Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nodal mantle cell lymphoma: a descriptive study from a tertiary care center in South India.
    Roy A; Kar R; Basu D
    Indian J Pathol Microbiol; 2013; 56(2):94-7. PubMed ID: 24056642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
    Espinet B; Salaverria I; Beà S; Ruiz-Xivillé N; Balagué O; Salido M; Costa D; Carreras J; Rodríguez-Vicente AE; Luís García J; Hernández-Rivas JM; Calasanz MJ; Siebert R; Ferrer A; Salar A; Carrió A; Polo N; García-Marco JA; Domingo A; González-Barca E; Romagosa V; Marugán I; López-Guillermo A; Millá F; Luís Mate J; Luño E; Sanzo C; Collado R; Oliver I; Monzó S; Palacín A; González T; Sant F; Salinas R; Ardanaz MT; Font L; Escoda L; Florensa L; Serrano S; Campo E; Solé F
    Genes Chromosomes Cancer; 2010 May; 49(5):439-51. PubMed ID: 20143418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.
    Stefancikova L; Moulis M; Fabian P; Falkova I; Vasova I; Kren L; Macak J; Smardova J
    J Clin Pathol; 2009 Oct; 62(10):948-50. PubMed ID: 19783727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mantle cell lymphoma diagnosis].
    Choukri M; Taheri H; Seddik R; Benkirane S; Hamama A; Masrar A; Agoumi NB; Chabraoui L
    Ann Biol Clin (Paris); 2013; 71(1):107-12. PubMed ID: 23396434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders.
    Wong KF; Chan JK; So JC; Yu PH
    Cancer; 1999 Sep; 86(5):850-7. PubMed ID: 10463985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.